Advertisement
Loading...

Natera, Inc.

NTRA•NASDAQ
Healthcare
Medical - Diagnostics & Research
$186.36
$-10.55(-5.36%)
U.S. Market opens in 37h 47m

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap26.7B
P/E Ratio-117.85
EPS (TTM)$-1.62
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$218.04
3 Months$221.91
1 Year Target$280.34

NTRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Natera, Inc. (NTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.49, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -117.85 and a market capitalization of 26.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.38%
5-Day Change
-11.28%
1-Month Change
-10.07%
3-Month Change
-9.65%
6-Month Change
-8.79%
Year-to-Date (YTD) Change
-18.67%
1-Year Change
24.71%
3-Year Change
257.14%
5-Year Change
102.94%
All-Time (Max) Change
935.11%

Contact Information

https://www.natera.com
650 249 9090
13011 McCallen Pass Building A, Austin, CA, 78753

Company Facts

4,424 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions